Orphan designation: puliretgene parvec Treatment of inherited retinal dystrophy due to dysfunction in the CYP4V2-gene, 12/09/2025 Positive | European Federation of Internal Medicine

Submitted by Anonymous (not verified) on 26 March 2026 - 13:22

Orphan designation: puliretgene parvec Treatment of inherited retinal dystrophy due to dysfunction in the CYP4V2-gene, 12/09/2025 Positive

Link:

https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-25-3171

Source:

Newsletters

Stay informed on our latest news!

Latest Newsletters